These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23827511)

  • 1. Modified Glasgow prognostic score in patients with incurable stage IV colorectal cancer.
    Kishiki T; Masaki T; Matsuoka H; Kobayashi T; Suzuki Y; Abe N; Mori T; Sugiyama M
    Am J Surg; 2013 Aug; 206(2):234-40. PubMed ID: 23827511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
    Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting survival in surgical palliative resection of stage IV colorectal cancer.
    Scabini S; Rimini E; Romairone E; Scordamaglia R; Pertile D; Ferrando V
    Minerva Chir; 2009 Jun; 64(3):303-6. PubMed ID: 19536056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer.
    Sugimoto K; Komiyama H; Kojima Y; Goto M; Tomiki Y; Sakamoto K
    Dig Surg; 2012; 29(6):503-9. PubMed ID: 23392422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K
    Ann Surg; 2007 Dec; 246(6):1047-51. PubMed ID: 18043109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph nodes ratio is associated with the survival of colorectal cancer patients with peritoneal carcinomatosis.
    Matsuda K; Hotta T; Takifuji K; Kobayashi Y; Tsuji T; Nagai Y; Horiuchi T; Yamaue H
    Am Surg; 2011 May; 77(5):602-7. PubMed ID: 21679595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
    Ahmed S; Leis A; Fields A; Chandra-Kanthan S; Haider K; Alvi R; Reeder B; Pahwa P
    Cancer; 2014 Mar; 120(5):683-91. PubMed ID: 24222180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival.
    Kobayashi T; Teruya M; Kishiki T; Endo D; Takenaka Y; Miki K; Kobayashi K; Morita K
    Dig Surg; 2010; 27(4):285-90. PubMed ID: 20689289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein is a negative independent factor in patients with stage IV colorectal cancer undergoing oxaliplatin-based chemotherapy.
    Fukuchi M; Kuwabara K; Tsuji Y; Baba H; Ishibashi K; Chika N; Hatano S; Matsuzawa T; Kumamoto K; Kumagai Y; Mochiki E; Ishida H
    Anticancer Res; 2013 Nov; 33(11):5051-5. PubMed ID: 24222149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection.
    Fujita S; Shimoda T; Yoshimura K; Yamamoto S; Akasu T; Moriya Y
    J Surg Oncol; 2003 Nov; 84(3):127-31. PubMed ID: 14598355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
    Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
    Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors of colorectal carcinoma in the elderly after radical surgery].
    Liang JW; Bai XF; Zhou ZX; Zhao DB; Wang CF; Zhao P
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1467-70. PubMed ID: 18953852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.
    Cianchi F; Messerini L; Comin CE; Boddi V; Perna F; Perigli G; Cortesini C
    Dis Colon Rectum; 2007 Sep; 50(9):1332-41. PubMed ID: 17429709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
    Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
    J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.
    Jeong JH; Lim SM; Yun JY; Rhee GW; Lim JY; Cho JY; Kim YR
    Oncology; 2012; 83(5):292-9. PubMed ID: 22964877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.